News
Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...
2h
HealthDay on MSNAmerican College of Physicians, April 3-5The annual meeting of the American College of Physicians (Internal Medicine Meeting) was held from April 3 to 5 in New ...
New research shows that people who take the weight-loss drug tirzepatide can keep most of the weight off for at least three ...
People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.
5h
Lancashire Evening Post on MSNLancashire mum loses 11st using Mounjaro after trying "every diet under the sun"Rebecca Banks, from Lancashire, had tried Saxenda jabs, Weight Watchers and fasting, but nothing seemed to work.
Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.
Taking tirzepatide drug once a week may produce clinically meaningful and sustained weight loss for at least 3 years in ...
A U.S. senator said a GLP-1 drug changed his life — and now he’s calling for widespread access to anti-obesity medications.
Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...
The results showed that weight loss was significant and mostly came from fat, not muscle. On average, women lost about 12% of ...
Joint Health Journey Shared by Meghan Trainor and Husband Daryl SabaraOn their Workin' On It podcast, singer Meghan Trainor ...
New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that around two thirds of participants of the SURMOUNT-1 trial had only regained 5% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results